Results 41 to 50 of about 5,308,235 (232)

CRISPR and Gene Augmentation Rescue Trabecular Meshwork Dysfunction in iPSC Models of Lowe Syndrome

open access: yesAdvanced Science, EarlyView.
By modeling Lowe syndrome using patient‐derived iPSCs, this study establishes a human disease model that faithfully recapitulates OCRL deficiency‐associated ciliary and cytoskeletal defects. The model enables evaluation of both mutation‐agnostic DNA augmentation and CRISPR‐mediated mutation correction strategies, both of which restore OCRL function and
Siyu Chen   +11 more
wiley   +1 more source

Life table for immunological failure among patients on anti-retroviral therapy (n = 1,282).

open access: yes, 2015
Life table for immunological failure among patients on anti-retroviral therapy (n = 1,282).
Susan Hattingh (737310)   +1 more
core   +1 more source

Important HIV-associated conditions in HIV-infected infants and children

open access: yesSouth African Family Practice, 2007
This article is the last in a series of 6 articles that discussed the management of HIV-infected children in a clinically orientated, practical and concise fashion.
H. Rabie   +7 more
doaj   +1 more source

PBRM1 Deficiency in Microglia Leads to Excessive Neurogenesis and Autism‐Like Behaviors via the CCL5‐CCR1/5‐β‐catenin Signaling Axis

open access: yesAdvanced Science, EarlyView.
Microglial PBRM1 deficiency drives excessive hippocampal neurogenesis by enhancing CCL5–CCR1/5 signaling, leading to autism‐like behaviors. A pro‐inflammatory IL1α+/TNFα+ microglial subset is identified as a key cellular contributor to this process. PBRM1 represses Ccl5 expression at the transcriptional level.
Yang‐Yang Duan   +12 more
wiley   +1 more source

Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia

open access: yesHIV/AIDS: Research and Palliative Care, 2023
Eshetu Erjino, Ermias Abera, Lire Lemma Tirore Department of Public Health, College of Medicine and Health Sciences, Wachemo University, Hossana, Sothern EthiopiaCorrespondence: Lire Lemma Tirore, Email ganetlemma@gmail.comBackground: Unsuppressed viral ...
Erjino E, Abera E, Lemma Tirore L
doaj  

HECTD1 Directs HIF‐1α to Facilitate Intestinal Inflammation and Carcinogenesis via Promoting Th17 Differentiation and Glycolysis

open access: yesAdvanced Science, EarlyView.
HECTD1 emerges as an upstream amplifier of Th17 metabolic programming by promoting K63‐linked ubiquitination of IGF2BP3 and enhancing HIF‐1α translation. HIF‐1α reciprocally drives HECTD1 transcription, establishing a positive regulatory loop that sustains glycolysis and Th17 differentiation.
Shuiyu Xu   +12 more
wiley   +1 more source

Mortality rates in time periods after commencement of anti-retroviral therapy.

open access: yes, 2013
Mortality rates in time periods after commencement of anti-retroviral therapy.
Tim Spelman (143159)   +10 more
core   +1 more source

Plasma Membrane Lipid Asymmetry Dynamically Regulates Passive Diffusion

open access: yesAdvanced Science, EarlyView.
Passive diffusion enables hydrophobic molecules to cross the plasma membrane and exert their biological functions. This study demonstrates that plasma membrane lipid asymmetry, dynamically regulated by lipid scrambling, determines membrane permeability to lipophilic molecules and thereby modulates their cellular activities.
Jieming Ping   +4 more
wiley   +1 more source

Immunological treatment failure among patients on anti-retroviral therapy (N = 1,321).

open access: yes, 2016
Immunological treatment failure among patients on anti-retroviral therapy (N = 1,321).
Susan Hattingh (737310)   +1 more
core   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

open access: yesBiotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy